demonstrated that the knockdown of IGF2BP3 significantly inhibited CRC proliferation by repressing the percentage of the S phase of the cell cycle but promoting cell cycle arrest in the G0/G1 phase. This evidence concerns the gene IGF2BP3 and colorectal carcinoma.